Magellan Health Inc
NASDAQ:MGLN
Intrinsic Value
Magellan Health, Inc. engages in the business of healthcare management. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of MGLN.
Magellan Health Inc's market capitalization is 2.5B USD.
MGLN stock price is 94.99 USD.
MGLN.
MGLN. Open DCF Valuation
MGLN. Open Relative Valuation
MGLN.
MGLN has positive three-year average ROE (Return on Equity): 9%. The company is efficient at transforming stockholders' equity into net income.
MGLN's Revenue has grown by 7% over the past 12 months.
MGLN has positive Free Cash Flow for the last twelve months.
MGLN's ROE (Return on Equity) for the past 12 months is positive and is equal to 17%.
MGLN's ROE (Return on Equity) has decreased in the last 3 years from 23% to 17%.
MGLN's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 1%.
MGLN has positive Net Income for the last twelve months.
MGLN has positive Gross Profit for the last twelve months.
MGLN has positive Operating Income for the last twelve months.
MGLN's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -17% to 1%.
MGLN has a very low three-year average ROIC (Return on Invested Capital): 1%. The company is not efficient at using invested capital to generate operating income.
MGLN's long-term assets (3B USD) exceed its long-term liabilties (1B USD).
MGLN has negative Net Debt. This means that the company has more cash and short-term investments (1B USD) than debt (516m USD).
MGLN's Altman Z-Score is very high and is equal to 3.42.
MGLN's short-term assets (2B USD) exceed its short-term liabilties (756m USD).
MGLN's D/E (Debt to Equity) is very low and is equal to 0.27.
MGLN generates enough operating income (50m USD) to cover interest payments on its debt (34m USD).
Fundamental Analysis
Magellan Health Inc
Balance Sheet Decomposition
Magellan Health Inc
| Current Assets | 2.2B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 835.3m |
| Other Current Assets | 197.3m |
| Non-Current Assets | 1.1B |
| PP&E | 167.5m |
| Intangibles | 57.1m |
| Other Non-Current Assets | 924.4m |
| Current Liabilities | 756m |
| Accounts Payable | 359m |
| Accrued Liabilities | 223.9m |
| Other Current Liabilities | 173.2m |
| Non-Current Liabilities | 663.5m |
| Long-Term Debt | 516.4m |
| Other Non-Current Liabilities | 147.2m |
Earnings Waterfall
Magellan Health Inc
|
Revenue
|
4.8B
USD
|
|
Cost of Revenue
|
-4.7B
USD
|
|
Gross Profit
|
143.6m
USD
|
|
Operating Expenses
|
-94m
USD
|
|
Operating Income
|
49.6m
USD
|
|
Other Expenses
|
252.4m
USD
|
|
Net Income
|
302m
USD
|
Free Cash Flow Analysis
Magellan Health Inc
MGLN Profitability Score
Profitability Due Diligence
Magellan Health Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Magellan Health Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
MGLN Solvency Score
Solvency Due Diligence
Magellan Health Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Magellan Health Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MGLN Price Targets Summary
Magellan Health Inc
Shareholder Return
MGLN Price
Magellan Health Inc
| Average Annual Return | 17.26% |
| Standard Deviation of Annual Returns | 6.96% |
| Max Drawdown | -60% |
| Market Capitalization | 2.5B USD |
| Shares Outstanding | 26 332 100 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Magellan Health Inc
Country
Industry
Market Cap
Dividend Yield
Description
Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).
You don't have any saved screeners yet
